Shirvan Mitchell
Insider CIK 1727789 · FOMX VP Innovation & Discovery · SLXN CSO and CDO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLXN Silexion Therapeutics Corp | A Award | 2026-06-04 | 2026-06-08 | 6,000 | — | $0 | 8,789 | SEC↗ |
| SLXN Silexion Therapeutics Corp | S Sale | 2026-03-26 | 2026-03-30 | 22,818 | $1.36 | $31.0K | 27,889 | SEC↗ |
| SLXN Silexion Therapeutics Corp | A Award | 2026-02-20 | 2026-02-23 | 49,726 | — | $0 | 50,707 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-02-27 | 2018-02-28 | 15,000 | $6.40 | $96.0K | 15,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2018-02-27 | 2018-02-28 | 5,000 | — | $0 | 24,980 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2018-01-15 | 2018-01-24 | 562 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2018-01-15 | 2018-01-24 | 562 | — | $0 | 19,980 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2018-01-01 | 2018-01-24 | 2,745 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2018-01-01 | 2018-01-24 | 2,745 | — | $0 | 19,980 | SEC↗ |